4-methyl-2-thien-2-yl-1,3-thiazole-5-carboxylic acid, 95.0%, 1g

4-Amino-2-naphthoic acid, 96%, 50mg

2,6-Dimethoxybenzaldehyde>97.0%(GC)5g

4-Amino-6-chloro-2-methylpyrimidine, 95.0%, 5g

(S)-1-(3,4-Difluorophenyl)ethanamine, 95.0%, 1g

n-(Cyclopropylmethyl)benzo[d][1,3]dioxol-5-amine, 95%, 50g

3-(2-Methoxyphenyl)isoxazole-5-carboxylic acid, 95.0%, 5g

5-(4-chlorophenyl)-4,5-dihydroisoxazole-3-carboxylic acid, 5g

GC capillary column ROTI®Cap-5 MS, 30 m, 0.25 mm, 0.50 µm, 1 Piece(s)

5,7-Dihydroxy-4-methyl-2-chromenone, 97.0%, 1g

3-Bromo-4-ethylbenzoic acid, 95.0%, 100mg

6-tert-Butyl-4,5,6,7-tetrahydrobenzothiazol-2-ylamine, 10g

2-Amino-N-(2-methoxyethyl)-4,5,6,7-tetrahydro-1-benzothiophene- 3-carboxamide, 95.0%, 2.5g